The outcomes of favipiravir exposure in pregnancy: a case series.

Ozge Ertem Ozge Guner Canet Incir Sule Kalkan Ayse Gelal

Published in: Archives of gynecology and obstetrics (2022)

The data indicate that favipiravir is not likely to be a major teratogen. Yet, it is not possible to draw a definite conclusion due to methodological limitations. Favipiravir exposures during pregnancy should be followed up closely and the outcomes should be reported consistently.

Keyphrases

electronic health record
big data
adipose tissue
metabolic syndrome
skeletal muscle
pregnancy outcomes
deep learning
artificial intelligence
data analysis